WHO team working with Chinese vaccine producers ahead of potential emergency use: WHO director-general

http://www.xinhuanet.com/english/2021-01/13/c_139663732.htm

HR Ministry: Employers to bear full cost to immunise foreign workers from Covid-19

https://www.malaymail.com/news/malaysia/2021/01/06/hr-ministry-employers-to-bear-full-cost-to-immunise-foreign-workers-from-co/1937854?utm_source=izooto&utm_medium=push_notifications&utm_campaign=HR%20Ministry:%20Employers%20to%20bear%20full%20cost%20to%20immuni

With its first home-grown Sinopharm Covid-19 vaccine granted conditional approval on December 30, 2020, China started the year 2021 with a plan to vaccinate 50 million people before February. The jabs will be given under a national inoculation programme to prepare the country for the movement of hundreds of millions of people who will travel across China for the Lunar New Year holiday which in 2021 will last from February 11 to 17.

https://www.youtube.com/watch?v=1UodJBLt55k

CGTN reporter visits vaccination site in Beijing
https://www.youtube.com/watch?v=kxVKJxSDmrQ

China starts vaccinating key groups before Spring Festival

https://www.youtube.com/watch?v=W0yprzb_7qE

Pakistan to purchase 1.2 million COVID-19 vaccine doses from China's Sinopharm
https://www.youtube.com/watch?v=tH2Jape6r-M

China Approves Sinopharm's Covid Vaccine for General Use
https://www.youtube.com/watch?v=yL4SDHEqGYE

Pakistan to purchase 1.2 million Covid-19 vaccine doses from China’s Sinopharm

https://www.freemalaysiatoday.com/category/business/2020/12/31/pakistan-to-purchase-1-2-million-covid-19-vaccine-doses-from-chinas-sinopharm/?utm_source=FCM&utm_medium=Push

China gives conditional approval for Sinopharm's Covid-19 vaccine

https://www.thestar.com.my/aseanplus/aseanplus-news/2020/12/31/china-gives-conditional-approval-for-sinopharm039s-covid-19-vaccine

China gives its first Covid-19 vaccine approval to Sinopharm

https://www.theedgemarkets.com/article/china-gives-its-first-covid19-vaccine-approval-sinopharm

Live: China holds news conference on COVID-19 Vaccine

https://www.youtube.com/watch?v=nNyd6hcmtYo

How the Sinopharm Vaccine

Workshttps://www.nytimes.com/interactive/2020/health/sinopharm-covid-19-vaccine.html

COVID-19 Vaccine: BBIBP-CorV (Update)

BIBP-CorV is one of two inactivated virus COVID-19 vaccine being developed by Sinopharm's Beijing and Wuhan subsidiaries.

By November, nearly one million people had taken the vaccine through China's emergency use program.[8]

As of December 2020, it is currently in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and United Arab Emirates with over 60,000 people.[8]

On December 9, the UAE announced the official registration of BBICP-CorV after an interim analysis of the Phase III trials showed BBIBP-CorV to have a 86% efficacy against COVID-19 infection.[9]


BIBP-CorV could become a favorable option to vaccinate large parts of the developing world. While mRNA vaccines like BNT162b2 and MRNA-1273 showed higher efficacy of +90%, those present distribution challenges for some nations as they require deep-freeze facilities and trucks. BIBP-CorV could be transported and stored at normal refrigerated temperatures.[10] While Pfizer and Moderna are among developers relying on novel technology, manufacturers have decades of experience with the method Sinopharm is using.[10]

@ularsawa, for glove counters, better you buy Glove counters that are already in operation, buy them when they are in the lows and wait for the fruits

IOIPG, vaccines linked?

https://www.theedgemarkets.com/article/ioi-properties-gets-uma-query-over-sharp-rise-share-price-volume

In any argument between Husband and Wife, the Wife must have the last words, any returning of fire will cause endless argument. So, Husband, you are the decider for the argument to end.

To ship at temperatures ranging from 2 to 8 degrees Celsius should be a piece of cake.

To ship frozen Musang King has even lower temperature requirement of -18°C

https://newleaf.com.my/durian-exporter-malaysia-musang-king-durian/

@Noobie123 Why Pfizer need legal indemnity?

Basically says, use it at your own risk, there are probably many unknown side-effect (if any) that the company would not want to be liable for. Considering it is a new untested type of Vaccines for mass vaccinations, the company would not want any endless lawsuits.

Which is the closest to regulatory approval?

Both Sinopharm and Sinovac seem to be running neck-and-neck.

Sinopharm subsidiary CNBG submitted an application to China’s Food and Drug Administration for regulatory approval this month, according to Chinese media reports last week. It’s unclear which of its two vaccine candidates the application was for, or if it applied for both.

Meanwhile, Brazilian regulators have said they expect to see the vaccine that has been tested there—Sinovac’s CoronaVac—get regulatory approval in China this month.

The “major announcement” teased by Wang, the deputy head of China’s task force on vaccine development, on Dec. 4, could refer to upcoming regulatory approval for one or more vaccines.

https://qz.com/1940097/what-we-know-about-chinas-covid-19-vaccines/

@eyehunter, The more important question is, is Bintai betting on a wrong horse (Generex) that is at Pre-clinical Trial (testing on animal).
So many horses are about to cross the finish line. Is Bintai going to be too late for the party?

@ularsawa, Sinopharm had done Phase 3 trial and now in final stage of approval. Whereas, IMBCAMS had done Phase 2 and now going into Phase 3.
Sinopharm is ahead of IMBCAMS in timeline. However both are using same type of Vaccines based on Inactivated SARS-CoV-2

https://en.wikipedia.org/wiki/COVID-19_vaccine#Clinical_trials_started_in_2020

In a do or die situation, the precedence is to save life than halal status of the jabs. But, ultimately it is up to the person to decide.

@18KHarmoni, Which 5 penny stock shares that you had invested? Care to share?

Decision on Covid-19 vaccination among Muslims now expected to be known next week

https://www.theedgemarkets.com/article/decision-covid19-vaccination-among-muslims-now-expected-be-known-next-week

If a horse that has almost little chance of crossing the finish line can up 34.9%, imagine of the horse that will cross the finish line very soon

By the logic, Bintai (Generex) is only in Pre-clinical stage (testing with animals), just like at starting point of the race, where is the momentum for its shares to be flying?

Can anyone explain why Bintai is flying, what has Bintai got in its pocket?

The shark want it up, sell to the shark. The shark want it down, buy from the shark. Correct?

Most Malaysian businesses only expect to return to pre-Covid profitability by end of 2022 — survey

https://www.theedgemarkets.com/article/most-malaysian-businesses-only-expect-return-precovid-profitability-end-2022-%E2%80%94-survey

@Noobie, CAMS uses Inactivated SARS-CoV-2,currently in Phase 2 Trial

https://en.wikipedia.org/wiki/COVID-19_vaccine#COVID%E2%80%9119_vaccine_development_in_2020

@ NPRA185, Oh Ok, noted

Covid-19 vaccine will be less than RM100 per dose, says Khairy

https://www.freemalaysiatoday.com/category/nation/2020/11/30/covid-19-vaccine-will-be-less-than-rm100-per-dose-says-khairy/

@Noobie, I am aware of Bintai's news

Interestingly, Bintai is on the rise, I can never find Generex Biotechnology's timeline, certainly not on the forerunner list

Ii-Key Platform Overview
The Ii-Key-SARS-CoV-2 vaccine is designed as a “Complete Vaccine” that has the potential to induce the T-Cell and antibody immune responses that can provide protective immunity with long-lasting immunologic memory against SARS-CoV-2 in a highly specific manner to ensure safety. Ii-Key is a platform technology enabled by the amino acid key sequence “LRMK” that is shared across the platform. The LRMK key sequence works by its ability to deliver any desired peptide epitope of interest directly to the MHC Class 2 complex on the surface of antigen presenting cells. Once a suitable target epitope is identified, an Ii-Key vaccine candidate is created by means of synthetic peptide synthesis, which produces a single linear amino acid chain that includes the Ii-Key sequence, a short inert linker sequence, and the target epitope of interest. In this way, the target epitope is delivered by the Ii-Key sequence directly to antigen presenting cells, resulting in an immune system stimulation.

@Noobie, Sinopharm, the other two (SinoVac, Cansino) are private (or semi-Govt?) owned

Infected after holiday to Europe, pregnant Singapore mum gives birth to baby with Covid-19 antibodies
https://www.straitstimes.com/singapore/infected-after-holiday-to-europe-pregnant-mum-gives-birth-to-baby-with-covid-19-antibodies

The Govt announcement on Pfizer is for Govt sector. It should not impact much on Kanger next week, the current price on Kanger had already factored in the fact that Kanger will focus on private healthcare.

Malaysia My Second Home (MM2H)
So far over 42,000 people have been approved for the MM2H visa.

This is just an entertainment read:

Kanger, the winter queen
https://kashmirreader.com/2020/11/29/kanger-the-winter-queen/

Malaysia is home to about 3 millions foreign workers, which made Malaysia the sixth-largest migrant-receiving countries in East Asia according to the World Bank's estimate. (Aug 20, 2020)

As soon as Covid-19 vaccines are approved, companies like Top Gloves should be running to get their foreign workers (FW) vaccinated. Unprotected FW is a huge risk to an organisation as Covid-19 is high infectious and can easily cause shutting down of factories. What happened in Top Gloves should be lesson for other factories.

(Disclaimer: The above is my personal view, it is not in anyway a view of Top Gloves)

NPRA1985, tomorrow is Sunday, rest day

Pets, cats and dogs also need the vaccines shots, they are family members.
Govt do not cover these.

Currently, how long will the vaccine immunity lasts is still not clear. Possible that might have to have booster shots after a while.

Also, do not underestimate Travellers' Covid-19 vaccine passports, most will seek private.

@ Noobie123, Boss paid for Foreign maids

LOL@ Noobie123, you going after Maids' Market share ke?

B40 and some M40 will go Govt healthcare.
Some M40 and T20 will go Private healthcare (OK Ok, maid also included lar)

FACT: People who have gotten sick with COVID-19 may still benefit from getting vaccinated

Due to the severe health risks associated with COVID-19 and the fact that re-infection with COVID-19 is possible, people may be advised to get a COVID-19 vaccine even if they have been sick with COVID-19 before.

At this time, experts do not know how long someone is protected from getting sick again after recovering from COVID-19. The immunity someone gains from having an infection, called natural immunity, varies from person to person. Some early evidence suggests natural immunity may not last very long.

We won’t know how long immunity produced by vaccination lasts until we have a vaccine and more data on how well it works.

Both natural immunity and vaccine-induced immunity are important aspects of COVID-19 that experts are trying to learn more about, and CDC will keep the public informed as new evidence becomes available.

Facts about COVID-19 Vaccines

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits/facts.html

@ Noobie123, yeah, 1000 yuan = RM620 (for two shots)

@ rezzare,how you work out RM600 for 2 shots? (price to patient?)